DD117223A5 - - Google Patents

Info

Publication number
DD117223A5
DD117223A5 DD185482A DD18548275A DD117223A5 DD 117223 A5 DD117223 A5 DD 117223A5 DD 185482 A DD185482 A DD 185482A DD 18548275 A DD18548275 A DD 18548275A DD 117223 A5 DD117223 A5 DD 117223A5
Authority
DD
German Democratic Republic
Application number
DD185482A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD117223A5 publication Critical patent/DD117223A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD185482A 1974-04-17 1975-04-16 DD117223A5 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
DD117223A5 true DD117223A5 (https=) 1976-01-05

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
DD185482A DD117223A5 (https=) 1974-04-17 1975-04-16

Country Status (21)

Country Link
US (1) US4009847A (https=)
JP (1) JPS50148349A (https=)
AR (1) AR208545A1 (https=)
CA (1) CA1047042A (https=)
CH (1) CH611292A5 (https=)
DD (1) DD117223A5 (https=)
DE (1) DE2516554A1 (https=)
DK (1) DK164175A (https=)
ES (1) ES436648A1 (https=)
FI (1) FI751128A7 (https=)
FR (1) FR2267773B1 (https=)
GB (1) GB1461209A (https=)
HU (1) HU173052B (https=)
IE (1) IE41143B1 (https=)
IL (1) IL47095A (https=)
LU (1) LU72306A1 (https=)
NL (1) NL7504570A (https=)
NO (1) NO144071C (https=)
PH (1) PH11722A (https=)
SE (1) SE417965B (https=)
YU (1) YU96075A (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
EP1158985B1 (en) * 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
ME00275B (me) 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
WO2003047579A1 (en) * 2001-12-03 2003-06-12 Bayer Pharmaceuticals Corporation Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
ATE529406T1 (de) * 2002-02-11 2011-11-15 Bayer Healthcare Llc Aryl-harnstoffe als kinase inhibitoren
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
SI1478358T1 (sl) 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
EP1636585B2 (en) * 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
EP1663978B1 (en) * 2003-07-23 2007-11-28 Bayer Pharmaceuticals Corporation Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
EP2295426A1 (en) * 2004-04-30 2011-03-16 Bayer HealthCare, LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
DK164175A (da) 1975-10-18
HU173052B (hu) 1979-02-28
FR2267773B1 (https=) 1978-08-18
IL47095A0 (en) 1975-06-25
ES436648A1 (es) 1977-08-01
SE417965B (sv) 1981-04-27
NO751351L (https=) 1975-10-20
YU96075A (en) 1983-04-27
CH611292A5 (https=) 1979-05-31
NO144071B (no) 1981-03-09
CA1047042A (en) 1979-01-23
US4009847A (en) 1977-03-01
IE41143L (en) 1975-10-17
IE41143B1 (en) 1979-10-24
DE2516554A1 (de) 1975-10-30
IL47095A (en) 1978-03-10
FR2267773A1 (https=) 1975-11-14
GB1461209A (en) 1977-01-13
NO144071C (no) 1981-06-17
AR208545A1 (es) 1977-02-15
JPS50148349A (https=) 1975-11-27
LU72306A1 (https=) 1976-03-17
SE7503523L (sv) 1975-10-20
NL7504570A (nl) 1975-10-21
FI751128A7 (https=) 1975-10-18
PH11722A (en) 1978-05-30
AU8013575A (en) 1976-10-21

Similar Documents

Publication Publication Date Title
FR2267773B1 (https=)
FI752091A7 (https=)
CS169440B1 (https=)
DE7405099U1 (https=)
CS175041B1 (https=)
CS164725B1 (https=)
BG19927A1 (https=)
BG19768A1 (https=)
AU480659A (https=)
DD119559A5 (https=)
DD113618A1 (https=)
CH611658A5 (https=)
CH608242A5 (https=)
BG19878A1 (https=)
CH606568A5 (https=)
CH601365A5 (https=)
CH595120A5 (https=)
CH576859A5 (https=)
BG19999A1 (https=)
BG19959A1 (https=)
BG19872A1 (https=)
BG19828A1 (https=)
BG19825A1 (https=)
BG19772A1 (https=)
DD114762A1 (https=)